Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;9(4):1595-1598.
doi: 10.21037/tlcr-20-653.

PET-Plan: potential for dose escalation by target volume reduction in locally advanced NSCLC

Evelyn E C de Jong  1 , Janita E van Timmeren  2
Affiliations
Editorial

PET-Plan: potential for dose escalation by target volume reduction in locally advanced NSCLC

Evelyn E C de Jong et al. Transl Lung Cancer Res. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure from (available at http://dx.doi.org/10.21037/tlcr-20-653). The authors have no conflicts of interest to declare.

Comment on

References

    1. Curran WJ, Jr, Paulus R, Langer CJ, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011;103:1452-60. 10.1093/jnci/djr325 - DOI - PMC - PubMed
    1. Machtay M, Paulus R, Moughan J, et al. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. J Thorac Oncol 2012;7:716-22. 10.1097/JTO.0b013e3182429682 - DOI - PMC - PubMed
    1. Nestle U, Schimek-Jasch T, Kremp S, et al. Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial. Lancet Oncol 2020;21:581-92. 10.1016/S1470-2045(20)30013-9 - DOI - PubMed
    1. van Diessen J, De Ruysscher D, Sonke JJ, et al. The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial). Radiother Oncol 2019;131:166-73. 10.1016/j.radonc.2018.09.019 - DOI - PubMed
    1. De Ruysscher D, Wanders S, van Haren E, et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 2005;62:988-94. 10.1016/j.ijrobp.2004.12.019 - DOI - PubMed